Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Envola | 2022 | Grant | $2.4M | Ulm |
| Klearia | 2022 | Grant | $2.2M | Valbonne |
| CH-Bioforce Oy | 2022 | Grant | $16.5M | Espoo |
| Dermagnostix | 2022 | Grant | $2.8M | Freiburg |
| Perha Pharmaceuticals | 2022 | Grant | $2.8M | Roscoff |
| Invivo Bionics | 2022 | Grant | $2.5M | Oslo |
| New Born Solutions | 2022 | Grant | $2.8M | Barcelona |
| EZMEMS | 2022 | Grant | $2.8M | Caesarea |
| Novolyze | 2022 | Series A | $15.0M | Bethesda |
| Freiburger Medizintechnik | 2022 | Grant | $1.5M | Freiburg Im Breisgau |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 501 | Envola | Grant | $2.4M | Ulm, Germany |
| 502 | Klearia | Grant | $2.2M | Valbonne, France |
| 503 | CH-Bioforce Oy | Grant | $16.5M | Espoo, Finland |
| 504 | Dermagnostix | Grant | $2.8M | Freiburg, Germany |
| 505 | Perha Pharmaceuticals | Grant | $2.8M | Roscoff, France |
| 506 | Invivo Bionics | Grant | $2.5M | Oslo, Norway |
| 507 | New Born Solutions | Grant | $2.8M | Barcelona, Spain |
| 508 | EZMEMS | Grant | $2.8M | Caesarea, Israel |
| 509 | Novolyze | Series A | $15.0M | Bethesda, United States |
| 510 | Freiburger Medizintechnik | Grant | $1.5M | Freiburg Im Breisgau, Germany |
Envola provides solutions for smart energy management, renewable energy resources, and energy storage.
Klearia is a spin-off born at the laboratory for photonics and nanostructures.
CH-Bioforce is the developer of the best biomass fractionation technology in the world.
Dermagnostix creates ground-breaking dermatology diagnostics to promote clinical practice and enhance patient experiences.
Perha Pharmaceuticals is a bio technology company which does research & development of kinase inhibitors.
Invivo Bionics offers micro and nano-technology designed to monitor the human bladder.
New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.
EZMEMS is an automation technology platform for smart plastic AIoT sensors.
Novolyze provides a platform to digitize food safety, quality, and sanitation processes for food and beverage manufacturers.
Freiburger Medizintechnik provides technology for quick and easy infection prevention that is made available to the dental community.
Make smarter decisions for your paid campaigns with superhuman automated keyword management.
Cardiac Success provides implant to improve cardiac function in patients with heart failure and/or functional mitral regurgitation.
Qnami develops quantum sensing technologies designed for nanoscale imaging.
BELKIN Vision develops a laser device to assist healthcare professionals in the treatment of glaucoma.
Medical device company focused on cartilage repair
CrayoNano is a semiconductor company, manufacturer of hybrid material based UV-C LEDs for disinfection.
Criam is a medtech company focused on blood type and disease detection.
Ladimo develops machine vision applications for different industry needs.
enGenome provides bioinformatics solutions for translational research and clinical routine.
DENS develops and produces energy systems based upon the LOHC Hydrozine
Seervision is a fledgling robotics startup that’s meshing machine learning, computer vision, and cinematography.
AVeta provides hormone free, safe, affordable and science backed treatment for underlying conditions of vaginal atrophy.
AgroBiogel creates superabsorbent material as well as agrochemical storage and slow-release systems for agricultural applications.
Simplicity Works develops its patented technology 3D Bonding - the simplest method for joining pieces.
Next Generation Sensors is a biotech company that develops mass spectrometers for life-science industrial applications.
European Innovation Council has invested in 594 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
European Innovation Council's top investment sectors include Health Care, Biotechnology, Medical Device, Manufacturing, Medical. The firm invests across 46 different industry categories.
Among tracked funding rounds, BELKIN Vision received $19.7M in a Grant round. European Innovation Council's total known invested capital is $4.5B.
European Innovation Council's average investment size is $11.4M across its portfolio of 594 companies.
Recent European Innovation Council portfolio additions include Envola, Klearia, CH-Bioforce Oy, Dermagnostix, Perha Pharmaceuticals. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors